MOTS-c 10mg | 10-Vial Kit | Metabolic Regulator
$210
QSC MOTS-c (Mitochondria-derived peptide) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
MOTS-c 10mg | 20-Vial Kit | Metabolic Regulator
$370
QSC MOTS-c (Mitochondria-derived peptide) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
MOTS-c 40mg | 10-Vial Kit | Metabolic Regulator
$350
QSC MOTS-c (Mitochondria-derived peptide) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
MOTS-c 40mg | 20-Vial Kit | Metabolic Regulator
$650
QSC MOTS-c (Mitochondria-derived peptide) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Orforglipron 12mg Tablets | 100-Count | GLP-1 Receptor Agonist
$310
QSC Orforglipron (Oral non-peptide GLP-1R agonist) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Orforglipron 6mg Tablets | 100-Count | GLP-1 Receptor Agonist
$230
QSC Orforglipron (Oral non-peptide GLP-1R agonist) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Orlistat 100G Raw Powder | Pancreatic Lipase Inhibitor
$500
QSC Orlistat (Pancreatic Lipase Inhibitor / Anti-Obesity Agent) — ≥99% HPLC purity, MS confirmed, Janoshik COA. 100G bulk. Research use only.
Orlistat 1KG Raw Powder | Pancreatic Lipase Inhibitor
$2,500
QSC Orlistat (Pancreatic Lipase Inhibitor / Anti-Obesity Agent) — ≥99% HPLC purity, MS confirmed, Janoshik COA. 1KG bulk. Research use only.
Retatrutide + Cagrilintide Blend 10mg | 10-Vial Kit | Triple/Dual Agonist Stack
$310
Retatrutide + Cagrilintide Blend 10mg | 10-Vial Kit — Long-acting amylin receptor agonist — reduces food intake via area postrema satiety signalling, slows gastric emptying, and suppresses postprandial glucagon independently of GLP-1 pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide + Cagrilintide Blend 10mg | 20-Vial Kit | Triple/Dual Agonist Stack
$570
Retatrutide + Cagrilintide Blend 10mg | 20-Vial Kit — Long-acting amylin receptor agonist — reduces food intake via area postrema satiety signalling, slows gastric emptying, and suppresses postprandial glucagon independently of GLP-1 pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 10mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$230
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 10mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$410
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 15mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$280
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 15mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$510
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 20mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$300
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 20mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$550
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 30mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$330
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 30mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$610
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 40mg | 10-Vial Kit | 400mg Total | Triple Agonist GIP/GLP-1/Glucagon
$420
Retatrutide 40mg — triple GLP-1R/GIPR/GCGR agonist, 24.2% Phase 2 weight loss. ≥99% HPLC, Janoshik COA. 10-vial kit. Research use only.
Retatrutide 40mg | 20-Vial Kit | 800mg Total | Triple Agonist GIP/GLP-1/Glucagon
$790
Retatrutide 40mg — triple GLP-1R/GIPR/GCGR agonist, 24.2% Phase 2 weight loss. ≥99% HPLC, Janoshik COA. 20-vial kit. Research use only.
Retatrutide 50mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$470
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 50mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$890
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 5mg | 10-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$190
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Retatrutide 5mg | 20-Vial Kit | Triple Agonist GIP/GLP-1/Glucagon
$330
QSC Retatrutide (Triple GLP-1R/GIPR/GCGR agonist (LY3437943)) — ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.